Literature DB >> 18455220

The effect of cationic charge on release of eosinophil mediators.

Darryl J Adamko1, Yingqi Wu, Farnam Ajamian, Ramses Ilarraza, Redwan Moqbel, Gerald J Gleich.   

Abstract

BACKGROUND: In patients with atopic diseases, cationic-charged eosinophil proteins are deposited in inflamed tissues. Although the role of cytokines in cell activation is well established, the presence of cationic-charged tissue can also be an important factor in inflammatory cell function.
OBJECTIVES: We sought to determine whether increased cationic charge seen in an atopic microenvironment plays a role in the activation of eosinophils.
METHODS: Human eosinophils were incubated with Sepharose beads coated with cationic or anionic compounds in the presence and absence of a cytokine cocktail (IL-3, IL-5, and GM-CSF) to simulate the milieu of inflammation. Eosinophil peroxidase and eosinophil-derived neurotoxin (EDN) release were compared with eosinophil morphology and expression of CD18, as determined by means of confocal microscopy.
RESULTS: Cytokines with positively charged beads caused greater eosinophil peroxidase release (lysine coated, 44.2 nmol/L; compound 48/80, 40.0 nmol/L; or EDN coated, 49.1 nmol/L) than cytokines alone (14.9 nmol/L). Beads coated with heparin, dextran sulfate, and aspartic acid did not show this effect. EDN release was also induced by lysine-coated beads with cytokines (67.1 ng/100 microL) and blocked by heparin. Eosinophil incubation with wortmannin, genistein, and the src kinase inhibitor PP1 blocked cationic signaling. Eosinophils adherent to cationic-charged beads but not anionic-charged beads show polarization of CD18 expression toward the bead's surface.
CONCLUSION: Cationic-charged surfaces induce increased eosinophil mediator release by increasing the density of CD18 expression available at the target surface.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18455220     DOI: 10.1016/j.jaci.2008.03.020

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  8 in total

1.  Lactoferrin regulates an axis involving CD11b and CD49d integrins and the chemokines MIP-1α and MCP-1 in GM-CSF-treated human primary eosinophils.

Authors:  Colleen S Curran; Paul J Bertics
Journal:  J Interferon Cytokine Res       Date:  2012-06-25       Impact factor: 2.607

2.  Siglec-7 on peripheral blood eosinophils: Surface expression and function.

Authors:  Fanny Legrand; Nadine Landolina; Ilan Zaffran; Robert O Emeh; Elizabeth Chen; Amy D Klion; Francesca Levi-Schaffer
Journal:  Allergy       Date:  2019-02-26       Impact factor: 13.146

3.  PI3K, ERK, p38 MAPK and integrins regulate CCR3-mediated secretion of mouse and human eosinophil-associated RNases.

Authors:  R Shamri; K M Young; P F Weller
Journal:  Allergy       Date:  2013-06-06       Impact factor: 13.146

4.  PI3-kinase regulates eosinophil and neutrophil degranulation in patients with allergic rhinitis and allergic asthma irrespective of allergen challenge model.

Authors:  Mary Kämpe; Maria Lampinen; Ingrid Stolt; Christer Janson; Gunnemar Stålenheim; Marie Carlson
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

Review 5.  Advances in mechanisms of asthma, allergy, and immunology in 2008.

Authors:  Joshua A Boyce; David Broide; Kenji Matsumoto; Bruce S Bochner
Journal:  J Allergy Clin Immunol       Date:  2009-03       Impact factor: 10.793

6.  New sensitization to house dust mites in cefteram-induced occupational asthma: a case report.

Authors:  Hyun Jung Jin; Jeong-Eun Kim; Joo-Hee Kim; Young-Min Ye; Hae-Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2011-02-14       Impact factor: 5.764

7.  Eosinophil ETosis-Mediated Release of Galectin-10 in Eosinophilic Granulomatosis With Polyangiitis.

Authors:  Mineyo Fukuchi; Yosuke Kamide; Shigeharu Ueki; Yui Miyabe; Yasunori Konno; Nobuyuki Oka; Hiroki Takeuchi; Souichi Koyota; Makoto Hirokawa; Takechiyo Yamada; Rossana C N Melo; Peter F Weller; Masami Taniguchi
Journal:  Arthritis Rheumatol       Date:  2021-08-11       Impact factor: 15.483

8.  Biofunctional core-shell polypyrrole-polyethylenimine nanocomplex for a locally sustained photothermal with reactive oxygen species enhanced therapeutic effect against lung cancer.

Authors:  Chih-Wei Chiang; Er-Yuan Chuang
Journal:  Int J Nanomedicine       Date:  2019-02-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.